#Investors:
Novartis delivered a solid second quarter, returning to sales growth driven by continued momentum from priority brands.
We remain on track to deliver our full-year guidance and mid-term outlook.*
Press release: novartis.social/6013v4CD7
Webcast:
An innovative medicines company working to reimagine medicine. See our community guidelines: go.novartis.social/4bqbjuA

